To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward stirrups, brace for the uncomfortable speculum or even take the time off from ...

HPV self-tests allow patients to collect a sample themselves, instead of having a healthcare provider collect it.

In early December, the American Cancer Society updated its guidelines for the first time since 2020. Now, all women ...

Screening for cervical cancer many soon be possible within the privacy of your own home. On May 9, the U.S. Food and Drug Administration approved the Teal Wand, a tamponlike tool people can use to ...

The American Cancer Society (ACS) released updated guidelines today for cervical cancer screening, reflecting advances in disease detection and accessibility in the United States. The updated ...

The American Cancer Society has endorsed self-collected vaginal samples for cervical cancer screening — a change medical experts say will help expand access and improve detection. The updated ACS ...

Patients at average risk of cervical cancer can self-collect samples at home for HPV analysis, per the American Cancer Society (ACS). Updated ACS guidelines allow discontinuing screening after ...

Cervical cancer is one of the most preventable forms of cancer. Effective screening can detect precancerous changes years before cancer develops. But more than 4,300 women will die from cervical ...

LOS ANGELES (KABC) -- Some women are afraid of Pap smears, many more find the appointments inconvenient. Now there's a new self-guided way to do this cervical cancer screening test at home. Bur ...

ORLANDO, Fla. — Using urine to screen for high-risk types of human papillomavirus (HPV) shows promise in potentially reaching women who decline or lack access to a Pap smear, researchers reported at ...

Receiving a sample collection kit by mail helped people who were behind on cervical cancer screening take part in this regular checkup. A clinical trial assessed whether mailing kits to take a cell ...

Cervical cancer screening adherence is below 10%, with frequent guideline updates causing confusion among patients and clinicians. The COVID-19 pandemic worsened nonadherence and HPV vaccine awareness ...